X
Record #47357

Harnessing TRAIL-induced apoptosis pathway for cancer immunotherapy and associated challenges

Publisher
Frontiers
Original paper date
Aug 20, 2021
Institution
Human Genetics Division, Medical Biotechnology Department, National Institute of Genetics Engineering and Biotechnology (NIGEB), Tehran, Iran · Faculty of Nursing, HRH Princess Chulabhorn College of Medical Science, Chulabhorn Royal Academy, Bangkok, Thailand · Department of Physiology, College of Medicine, University of Suleimanyah, Suleimanyah, Iraq · Department of Medical Laboratory Sciences, Komar University of Science and Technology, Sulaimaniyah, Iraq · Institute of Pharmacy, Sechenov First Moscow State Medical University, Moscow, Russia · Laboratory of Food Chemistry, Federal Research Center of Nutrition, Biotechnology and Food Safety, Moscow, Russia · Department of Health and Rehabilitation Sciences, College of Applied Medical Sciences, Prince Sattam bin Abdulaziz University, Al Kharj, Saudi Arabia · Department of Physical Therapy, Kasr Al-Aini Hospital, Cairo University, Giza, Egypt · Department of Applied Cell Sciences, School of Advanced Technologies in Medicine, Tehran University of Medical Sciences, Tehran, Iran · Immunology Research Center (IRC), Tabriz University of Medical Sciences, Tabriz, Iran · Stem Cell Transplantation and Regenerative Medicine, Department of Pediatrics, Stanford University School of Medicine, Palo Alto, CA, United States · Toxicology and Chemotherapy Unit (G401), German Cancer Research Center, Heidelberg, Germany
Open access
No
Article type
Review Article
Broad categories
(BLS) Biochemistry(BLS) Biology - Cancer(BLS) Biology - Cellular
Notes from Retraction Watch

see also: https://blog.frontiersin.org/2023/09/04/frontiers-implements-new-policy-to-counter-authorship-for-sale/

Citation lifecycle

How this paper is being cited

Pre-retraction
24
Same day
0
Post-retraction
20
% post-retraction
46.5%
~11.8 citations/yr before retraction · ~6.6 citations/yr after
— citing papers

Who is still citing this work

Loading…
Back to browse